Browse > Article

Fluoxetine and Sertraline Attenuate Postischemic Brain Injury in Mice  

Shin, Tae-Kyeong (Department of Pharmacology, Medical Research Center for Ischemic Tissue Regeneration, Pusan National University School of Medicine)
Kang, Mi-Sun (Department of Pharmacology, Medical Research Center for Ischemic Tissue Regeneration, Pusan National University School of Medicine)
Lee, Ho-Youn (Department of Pharmacology, Medical Research Center for Ischemic Tissue Regeneration, Pusan National University School of Medicine)
Seo, Moo-Sang (Department of Pharmacology, Medical Research Center for Ischemic Tissue Regeneration, Pusan National University School of Medicine)
Kim, Si-Geun (Department of Pharmacology, Medical Research Center for Ischemic Tissue Regeneration, Pusan National University School of Medicine)
Kim, Chi-Dae (Department of Pharmacology, Medical Research Center for Ischemic Tissue Regeneration, Pusan National University School of Medicine)
Lee, Won-Suk (Department of Pharmacology, Medical Research Center for Ischemic Tissue Regeneration, Pusan National University School of Medicine)
Publication Information
The Korean Journal of Physiology and Pharmacology / v.13, no.3, 2009 , pp. 257-263 More about this Journal
Abstract
This study aimed to investigate whether selective serotonin reuptake inhibitors (SSRIs) attenuate brain injury and facilitate recovery following photothrombotic cortical ischemia in mice. Male ICR mice were anesthetized and systemically administered Rose Bengal. Permanent focal ischemia was induced in the medial frontal and somatosensory cortices by irradiating the skull with cold light laser. The animals were treated with fluoxetine or sertraline once a day for 14 d starting 1 h after ischemic insult. Treatment with fluoxetine and sertraline significantly reduced the infarct size. The Evans blue extravasation indices of the fluoxetine- and sertraline-treated groups were significantly lower than that of the vehicle group. Treatment with fluoxetine and sertraline shifted the lower limit of the mean arterial blood pressure for cerebral blood flow autoregulation toward normal, and significantly increased the expression of heme oxygenase-1 (HO-1) and hypoxia-inducible factor-1 ${\alpha}$ (HIF-1 ${\alpha}$) proteins in the ischemic region. These results suggest that SSRIs, such as fluoxetine and sertraline, facilitate recovery following photothrombotic cortical ischemia via enhancement of HO-1 and HIF-1 ${\alpha}$ proteins expression, thereby providing a benefit in therapy of cerebral ischemia.
Keywords
Cerebral blood flow autoregulation; Focal cerebral ischemia; Heme oxygenase-1; Hypoxia-inducible factor-1 ${\alpha}$; Selective serotonin reuptake inhibitors;
Citations & Related Records

Times Cited By Web Of Science : 4  (Related Records In Web of Science)
Times Cited By SCOPUS : 6
연도 인용수 순위
1 Acker T, Acker H. Cellular oxygen sensing need in CNS function: physiological and pathological implications. J Exp Biol 207: 3171−3188, 2004   DOI   ScienceOn
2 Betz AL. Vasogenic brain edema. In: Welch KMA, Caplan LR, Reis DJ, Siesj BK, Weir B, ed, Primer on cerebrovascular diseases. San Diego: Academic Press, p 56−159, 1997
3 Bonvento G, MacKenzie ET, Edvinsson L. Serotonergic innervation of the cerebral vasculature: relevance to migraine and ischaemia. Brain Res Brain Res Rev 16: 257−263, 1991   DOI   PUBMED   ScienceOn
4 Le Poul E, Boni C, Hanoun N, Laporte AM, Laaris N, Chauveau J, Hamon M, Lanfumey L. Differential adaption of brain 5-HT1A and 5-HT1B receptors and 5-HT transporter in rats treated chronically with fluoxetine. Neuropharmacology 39: 110−122, 2000   DOI   ScienceOn
5 Maines MD. The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol 37: 517−554, 1997
6 Rasmussen A, Lunde M, Poulsen DL, Sørensen K, Qvitzau S, Bech P. A double-blind, placebo-controlled study of sertraline in the prevention of depression in stroke patients. Psychosomatics 44: 216−221, 2003   DOI   ScienceOn
7 Sanchez V, Camarero J, Esteban B, Peter MJ, Green AR, Colado MI. The mechanisms involved in the long-lasting neuroprotective effect of fluoxetine against MDMA ('ecstasy')-induced degeneration of 5-HT nerve endings in rat brain. Br J Pharmacol 134: 46−57, 2001   DOI   ScienceOn
8 Semenza GL. Surviving ischemia: adaptive responses mediated by hypoxia-inducible factor 1. J Clin Invest 106: 809−812, 2000   DOI   ScienceOn
9 Marks GS, Brien JF, Nakatsu K, McLaughlin BE. Does carbon monoxide have a physiological function? Trends Pharmacol Sci 12: 185−188, 1991   DOI   ScienceOn
10 Kim JS, Choi S, Kwon SU, Seo YS. Inability to control anger or aggression after stroke. Neurology 58: 1106−1108, 2002   DOI   PUBMED   ScienceOn
11 Starkstein SE, Robinson RG. Affective disorders and cerebral vascular disease. Br J Psychiatry 154: 170−182, 1989   DOI   ScienceOn
12 Duman RS, Heninger GR, Nestler EJ. A molecular and cellular theory of depression. Arch Gen Psychiatry 54: 597−606, 1997   DOI   PUBMED   ScienceOn
13 Rampello L, Battaglia G, Raffaele R, Vecchio I, Alvano A. Is it safe to use antidepressants after a stroke? Expert Opin Drug Saf 4: 885−897, 2005   DOI   ScienceOn
14 Dijkhuizen RM, Ren J, Mandeville JB, Wu O, Ozdag FM, Moskowitz MA, Rosen BR, Finklestein SP. Functional magnetic resonance imaging of reorganization in rat brain after stroke. Proc Natl Acad Sci U S A 98: 12766−12771, 2001.   DOI   ScienceOn
15 Otterbein LE, Choi AM. Heme oxygenase: colors of defense against cellular stress. Am J Physiol Lung Cell Mol Physiol 279: L1029−L1037, 2000
16 Andersen G, Vestergaard K, Riis J, Lauritzen L. Incidence of post-stroke depression during the first year in a large unselected stroke population determined using a valid standardized rating scale. Acta Psychiatr Scand 90: 190−195, 1994b   DOI   ScienceOn
17 Chiou SH, Chen SJ, Peng CH, Chang YL, Ku HH, Hsu WM, Ho LL, Lee CH. Fluoxetine up-regulates expression of cellular FLICE-inhibitory protein and inhibits LPS-induced apoptosis in hippocampus-derived neural stem cell. Biochem Biophys Res Commun 343: 391−400, 2006   DOI   ScienceOn
18 Kreiss DS, Lucki I. Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine. J Pharmacol Exp Ther 274: 866−867, 1995
19 Paolucci S, Antonucci G, Grasso MG, Morelli D, Troisi E, Coiro P, De Angelis D, Rizzi F, Bragoni M. Post-stroke depression, antidepressant treatment and rehabilitation results. A case-control study. Cerebrovasc Dis 12: 264−271, 2001   DOI   ScienceOn
20 Ryter SW, Otterbein LE, Morse D, Choi AM. Heme oxygenase/ carbon monoxide signaling pathways: regulation and functional significance. Mol Cell Biochem 234−235: 249−263, 2002
21 Verma A, Hirsch DJ, Glatt CE, Ronnett GV, Snyder SH. Carbon monoxide: a putative neural messenger. Science 259: 381−384, 1993   DOI   PUBMED   ScienceOn
22 Goodwin GM, de Souza RJ, Green AR. Attenuation by electroconvulsive shock and antidepressant drugs of the 5-HT1A receptor- mediated hypothermia and serotonin syndrome produced by 8-OH-DPAT in the rat. Psychopharmacology 91: 500−505, 1987   DOI   PUBMED   ScienceOn
23 Pulsinelli WA. Selective neuronal vulnerability: morphological and molecular characteristics. Prog Brain Res 63: 29−37, 1985   DOI   PUBMED   ScienceOn
24 Bidmon HJ, Emde B, Oermann E, Kubitz R, Witte OW, Zilles K. Heme oxygenase-1 (HSP-32) and heme oxygenase-2 induction in neurons and glial cells of cerebral regions and its relation to iron accumulation after focal cortical photothrombosis. Exp Neurol 168: 1−22, 2001   DOI   ScienceOn
25 Hensler JG, Kovachich GB, Frazer A. A quantitative autoradiographic study of serotonin1A receptor regulation. Effect of 5,7 dihydroxytryptamine and antidepressant treatments. Neuropsychopharmacology 4: 131−144, 1991   PUBMED   ScienceOn
26 Panahian N, Yoshiura M, Maines MD. Overexpression of heme oxygenase-1 is neuroprotective in a model of permanent middle cerebral artery occlusion in transgenic mice. J Neurochem 72: 1187−1203, 1999   DOI   PUBMED   ScienceOn
27 Dam M, Tonin P, De Boni A, Pizzolato G, Casson S, Ermani M, Freo U, Piron L, Battistin L. Effects of fluoxetine and maprotiline on functional recovery in post-stroke hemiplegic patients undergoing rehabilitation therapy. Stroke 27: 1211−1214, 1996   PUBMED   ScienceOn
28 Demougeot C, Van Hoecke M, Bertrand N, Prigent-Tessier A, Mossiat C, Beley A, Marie C. Cytoprotective efficacy and mechanisms of the liposoluble iron chelator 2,2'-dipyridyl in the rat photothrombotic ischemic stroke model. J Pharmacol Exp Ther 311: 1080−1087, 2004   DOI   ScienceOn
29 Malberg JE. Implications of adult hippocampal neurogenesis in antidepressant action. J Psychiatry Neurosci 29: 196−205, 2004   PUBMED   ScienceOn
30 Parikh RM, Robinson RG, Lipsey JR, Starkstein SE, Fedoroff JP, Price TR. The impact of post-stroke depression on recovery in activities of daily living over a 2-year follow-up. Arch Neurol 47: 785−789, 1990   DOI   PUBMED   ScienceOn
31 Jakovljevic D, Tuomilehto J. Use of selective serotonin reuptake inhibitors and the risk of stroke: is there reason for concern? Stroke 33: 1448−1449, 2002   DOI   ScienceOn
32 Robinson RG, Schultz SK, Castillo C, Kopel T, Kosier JT, Newman RM, Curdue K, Petracca G, Starkstein SE. Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind study. Am J Psychiatry 157: 351−359, 2000   DOI   ScienceOn
33 Geddes JW, Pettigrew LC, Holtz ML, Craddock SD, Maines MD. Permanent focal and transient global cerebral ischemia increase glial and neuronal expression of heme oxygenase-1, but not heme oxygenase-2 protein in rat brain. Neurosci Lett 210: 205−208, 1996   DOI   ScienceOn
34 Ishii H, Bertrand N, Stanimirovic D, Strasser A, Mrsulja BB, Spatz M. The relationship between cerebral ischemic edema and monoamines: revisited. Acta Neurochir Suppl (Wien) 60: 238−241, 1994   PUBMED   ScienceOn
35 Nimura T, Weinstein PR, Massa SM, Panter S, Sharp FR. Heme oxygenase-1 (HO-1) protein induction in rat brain following focal ischemia. Brain Res Mol Brain Res 37: 201−208, 1996   DOI   PUBMED   ScienceOn
36 Bhardwaj A, Alkayed NJ, Kirsch JR, Hurn PD. Mechanisms of ischemic brain damage. Curr Cardiol Rep 5: 160−167, 2003   DOI   ScienceOn
37 Hanlon CA, Buffington AL, McKeown MJ. New brain networks are active after right MCA stroke when moving the ipsilesional arm. Neurology 64: 114−120, 2005   DOI   PUBMED   ScienceOn
38 Nakayama H, Jorgensen HS, Raaschou HO, Olsen TS. The influence of age on stroke outcome. The Copenhagen Stroke Study. Stroke 25: 808−813, 1994   DOI   PUBMED   ScienceOn
39 Blier P, de Montigny C. Current advances and trends in the treatment of depression. Trends Pharmacol Sci 15: 220−226, 1994   DOI   ScienceOn
40 Bonne O, Krausz Y, Gorfine M, Karger H, Gelfin Y, Shapira B, Chisin R, Lerer B. Cerebral hypoperfusion in medication resistant, depressed patients assessed by Tc99m HMPAO SPECT. J Affect Disord 41: 163−171, 1996   DOI   ScienceOn
41 Primeau F. Post-stroke depression: a critical review of the literature. Can J Psychiatry 33: 757−765, 1988   PUBMED   ScienceOn
42 Bederson JB, Pitts LH, Germano SM, Nishimura MC, Davis RL, Bartkowski HM. Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke 17: 1304−1308, 1986   DOI   PUBMED   ScienceOn
43 Harukuni I, Bhardwaj A. Mechanisms of brain injury after global cerebral ischemia. Neurol Clin 24: 1−21, 2006   DOI   ScienceOn
44 Muhonen MG, Robertson SC, Gerdes JS, Loftus CM. Effects of serotonin on cerebral circulation after middle cerebral artery occlusion. J Neurosurg 87: 301−306, 1997   DOI   ScienceOn
45 Bhogal SK, Teasell R, Foley N, Speechley M. Heterocyclics and selective serotonin reuptake inhibitors in the treatment and prevention of post-stroke depression. J Am Geriatr Soc 53: 1051−1057, 2005   DOI   ScienceOn
46 Li Q, Muma NA, Van de Kar LD. Chronic fluoxetine induces a gradual desensitization of 5-HT1A receptors: reductions in hypothalamic and midbrain Gi and Go proteins and in neuroendocrine responses to a 5-HT1A agonist. J Pharmacol Exp Ther 279: 1035−1042, 1996   ScienceOn
47 Ramasubbu R, Patten SB. Effect of depression on stroke morbidity and mortality. Can J Psychiatry 48: 250−257, 2003   ScienceOn
48 Arboix A, Garcia-Eroles L, Comes E, Oliveres M, Balcells M, Pacheco G, Targa C. Predicting spontaneous early neurological recovery after acute ischemic stroke. Eur J Neurol 10: 429−435, 2003   DOI   ScienceOn
49 Gainotti G, Antonucci G, Marra C, Paolucci S. Relation between depression after stroke, antidepressant therapy, and functional recovery. J Neurol Neurosurg Psychiatry 71: 258−261, 2001   DOI   ScienceOn
50 Dawn B, Bolli R. HO-1 induction by HIF-1: a new mechanism for delayed cardioprotection? Am J Physiol Heart Circ Physiol 289: H522−H524, 2005   DOI   ScienceOn
51 Welch KM, Chabi E, Buckingham J, Bergin B, Achar VS, Meyer JS. Cathecholamine and 5-hydroxytryptamine levels in ischemic brain. Influence of p-chlorophenylalanine. Stroke 8: 341−346, 1977   DOI   PUBMED   ScienceOn
52 Kotila M, Numminen H, Waltimo O, Kaste M. Post-stroke depression and functional recovery in a population-based stroke register. The Finnstroke study. Eur J Neurol 6: 309−312, 1999   DOI   ScienceOn
53 Ungvari Z, Pacher P, Kecskemeti V, Koller A. Fluoxetine dilates isolated small cerebral arteries of rats and attenuates constrictions to serotonin, norepinephrine, and a voltage-dependent $Ca^{2+}$ channel opener. Stroke 30: 1949−1954, 1999   DOI   PUBMED   ScienceOn
54 Fu R, Zhao ZQ, Zhao HY, Zhao JS, Zhu XL. Expression of heme oxygenase-1 protein and messenger RNA in permanent cerebral ischemia in rats. Neurol Res 28: 38−45, 2006   DOI   ScienceOn
55 Semenza GL. Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology. Trends Mol Med 7: 345−350, 2001   DOI   PUBMED   ScienceOn
56 Lee PJ, Jiang BH, Chin BY, Iyer NV, Alam J, Semenza GL, Choi AM. Hypoxia-inducible factor-1 mediates transcriptional activation of the heme oxygenase-1 gene in response to hypoxia. J Biol Chem 272: 5371−5381, 1997   DOI   ScienceOn
57 Uyama O, Okamura N, Yanase M, Narita M, Kawabata K, Sugita M. Quantitative evaluation of vascular permeability in the gerbil brain after transient ischemia using Evans blue fluorescence. J Cereb Blood Flow Metab 8: 282−284, 1988   DOI